Residual volume in vials of antibiotics used in pediatrics

Caroline Magna Pessoa Chaves1, Carolina Martins Bezerra1, Francisca Elisângela Teixeira Lima1

  • 1Universidade Federal do Ceará, Departamento de Enfermagem, Programa de Pós-Graduação em Enfermagem, Fortaleza, CE, Brasil.

Abstract

Insights

This study quantified residual antibiotic volumes in pediatric vials, finding significant waste in 74.28% of procaine benzylpenicillin + potassium benzylpenicillin vials. Improved antibiotic management and disposal are crucial for patient safety and environmental protection.

Area of Science:

  • Pharmacology
  • Hospital Pharmacy
  • Public Health

Background:

  • Antibiotic vials often contain residual volumes after administration.
  • Inadequate management of these residual volumes can lead to drug waste and potential health risks.
  • Pediatric care frequently involves the use of multiple antibiotic formulations.

Purpose of the Study:

  • To quantify the residual volume in antibiotic vials used in pediatric settings.
  • To assess the extent of antibiotic waste due to residual volumes.
  • To identify specific antibiotic formulations with higher residual volumes.

Main Methods:

  • A total of 105 antibiotic vials from pediatric use were analyzed.
  • Residual volume was determined by gravimetric analysis (weight difference before and after washing).
  • Statistical evaluation employed the Wilcoxon non-parametric test at a 5% significance level.

Main Results:

  • Oxacillin (88.57%) and ceftriaxone (94.28%) showed predominantly low residual volumes, indicating effective use.
  • Procaine benzylpenicillin + potassium benzylpenicillin exhibited significant waste, with 74.28% of vials having excessive residual volume.
  • The findings highlight variability in residual volume across different antibiotic types.

Conclusions:

  • There is a need for improved antibiotic management protocols in pediatric institutions.
  • Optimizing the use of residual antibiotic volumes within their stability period is essential.
  • Proper disposal of residual antibiotic volumes is critical to mitigate public health and environmental risks.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434
Respiratory Volumes01:15

Respiratory Volumes

Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
3.2K
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
286
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392